Thursday, October 31, 2024

New study shows combination therapy slows cognitive decline in at-risk populations

An important new study has demonstrated that a combination therapy can slow cognitive decline in older adults at risk for dementia.

from Top Health News -- ScienceDaily https://ift.tt/ZNhcCAJ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...